FAHIM RAAFAT E F 5
5 · NABI BIOPHARMACEUTICALS · Filed Feb 9, 2009
Insider Transaction Report
Form 5
FAHIM RAAFAT E F
DirectorPresident, CEO and CFO
Transactions
- Other
Common Stock
2008-11-28$3.39/sh+3,833.112$13,000→ 225,063.534 total - Award
Common Stock
2008-04-01+45,000→ 221,230.422 total - Award
Stock Option (Right to Buy)
2008-04-01+115,000→ 115,000 totalExercise: $3.95Exp: 2015-04-01→ Common Stock (115,000 underlying)
Footnotes (4)
- [F1]Restricted Stock which vests in four equal annual installments beginning on April 1, 2009
- [F2]Updates the total number of securities owned as of March 7, 2008 (122,167.2651 shares) last reported on a Form 4 on that date to reflect the award of 45,000 shares on April 1, 2008.
- [F3]Voluntarily reported acquisition under the Issuer's 2000 Employee Stock Purchase Plan, which is an exempt transaction pursuant to Rule 16b-3.
- [F4]The Option will become exercisable in four equal annual installments beginning on April 1, 2009